Victoria Socha

DocwireNews

Kidney Week 2020The Centers for Medicare &amp; Medicaid Services End Stage Renal Disease (<a href="https://www.docwirenews.com/nephtimes/nephtimes-features/nephtimes-columns/nephtimes-from-the-field/esrd-treatment-choices-model-overview/">ESRD</a>) Treatment Choices (ETC) Model will begin on January 1, 2021. The ETC is a mandatory payment model that assigns financial bonuses and penalties to dialysis facilities as a function of home dialysis prevalence and the incidence of kidney transplantation among patients with Medicare fee-for-service coverage.Kristine Kubisiak and colleagues conducted an analysis using claims data to estimate distributions of facility-level dialysis prevalence and incidence of kidney transplantation. Results of the analysis were reported during a virtual poster session at ASN Kidney Week 2020 in a <a href="https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3446442">poster</a> titled Home Dialysis and Kidney Transplant Assessments in the ESRD Treatment Choices Payment Model.The analysis included data from Medicare Limited Data Sets, used to identify all Part B claims for outpatient dialysis for the treatment of ESRD in 2017. The researchers estimated the percentage of patient-months with any home dialysis treatment in each dialysis facility with &ge;132 adult patient-months. Part A 2017 claims were used to estimate the number of kidney transplants among dialysis patients in each facility.The analysis identified 6263 dialysis facilities representing 3,645,655 patient-months. Overall prevalence of home dialysis was 10.8%. The analysis revealed three features regarding the distribution of facility-level home dialysis prevalence: (1) more than 54% of facilities has exactly 0% home dialysis prevalence; (2) among facilities with any home dialysis utilization, there was a unimodal distribution with peak prevalence near 12%; and (3) a small subset of facilities (4%) had home dialysis prevalence &gt;90%.More than half of the facilities had one or more kidney transplant. The 75th and 90th percentiles of transplant count were 2 and 4, respectively.In conclusion, the researchers said, &ldquo;In patients with Medicare fee-for-service coverage, facility-level dialysis prevalence exhibits a nonnormal distribution, while kidney transplant incidence typically manifests few (or no) events per year. Both patterns will complicate statistical analysis of performance in the ETC model. Alternative methodology should consider assessments in regional clusters of facilities.&rdquo;Source: Kubisiak K, Weinhandl ED, Dalrymple Ls, Kossmann RJ. Home dialysis and kidney transplant assessments in the ESRD Treatment Choices Payment model. Abstract of a poster presented at the American Society of Nephrology virtual Kidney Week 2020 (PO1242), October 22, 2020. Funding for this poster was supplied by Fresenius Medical Care.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

CMS ETC Payment Model and Dialysis Preference and Transplant Incidence

End-Stage Renal Disease

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe